UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000061064
Receipt number R000069874
Scientific Title Effect of a lower-sodium, potassium-enriched salt substitute on the urinary Na/K ratio in healthy young adults
Date of disclosure of the study information 2026/04/01
Last modified on 2026/03/26 13:24:31

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Does a salt substitute seasoning reduce the urinary Na/K ratio in healthy young adults ?

Acronym

Does a salt substitute reduce the urinary Na/K ratio?

Scientific Title

Effect of a lower-sodium, potassium-enriched salt substitute on the urinary Na/K ratio in healthy young adults

Scientific Title:Acronym

Effect of a salt substitute (NaCl/KCl) on the urinary Na/K ratio

Region

Japan


Condition

Condition

Excess sodium intake and low potassium intake (risk factors for hypertension and cardiovascular diseases)

Classification by specialty

Medicine in general Cardiology Geriatrics

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the feasibility and effect of a potassium-enriched salt substitute seasoning on urinary sodium-to-potassium ratio in healthy adults.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Change in urinary sodium-to-potassium (Na/K) ratio (mol/mol) between pre-intervention and post-intervention periods, assessed using repeated samples.

Key secondary outcomes

Estimated 24-hour sodium and potassium excretion (Kawasaki Method)
Acceptability and palatability of the seasoning (questionnaire)


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Food

Interventions/Control_1

Participants will consume a potassium-enriched salt substitute (NaCl/KCl) furikake seasoning (2.0 g per dose, twice daily, total 4 g/day) for 10 consecutive days. The salt substitute contains approximately 50% potassium chloride and 50% sodium chloride.
Participants will be instructed to use the seasoning with meals (e.g., with rice or side dishes) .
The second urine before and during the intervention were collected (3-5 times), and analyzed for urinary Na/K ratio.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit

25 years-old >=

Gender

Male and Female

Key inclusion criteria

Healthy students of Aichi Gakuin University aged from 18 to 25 years

Key exclusion criteria

History of kidney disease
Current treatment for heart failure or hypertension
Allergy to any components of the seasoning (e.g., sesame, spices)
Use of medications or supplements affecting sodium or potassium balance (e.g., diuretics, potassium supplements)

Target sample size

35


Research contact person

Name of lead principal investigator

1st name Wakako
Middle name
Last name Maruyama

Organization

Aichi Gakuin University

Division name

Department of Health and Nutritional Sciences, Faculty of Health Sciences

Zip code

470-0195

Address

12 Araike, Iwasaki-cho, Nisshin-shi, Aichi

TEL

81-561-73-1111

Email

maruyama@dpc.agu.ac.jp


Public contact

Name of contact person

1st name Wakako
Middle name
Last name Maruyama

Organization

Aichi Gakuin University

Division name

Department of Health and Nutritional Sciences, Faculty of Health Sciences

Zip code

470-0195

Address

12 Araike, Iwasaki-cho, Nisshin-shi, Aichi

TEL

81-561-73-1111

Homepage URL


Email

maruyama@dpc.agu.ac.jp


Sponsor or person

Institute

Aichi Gakuin University

Institute

Department

Personal name



Funding Source

Organization

Aichi Gakuin University

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Aichi Gakuin University

Address

12 Araike, Iwasaki-cho, Nisshin-shi, Aichi

Tel

81-561-73-1111

Email

m-ccc@dpc.agu.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2026 Year 04 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2026 Year 03 Month 31 Day

Date of IRB

2026 Year 03 Month 14 Day

Anticipated trial start date

2026 Year 04 Month 01 Day

Last follow-up date

2029 Year 03 Month 01 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2026 Year 03 Month 26 Day

Last modified on

2026 Year 03 Month 26 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000069874